Rankings
▼
Calendar
VTRS Q1 2022 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$17B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.2B
-5.4% YoY
Gross Profit
$1.8B
42.3% margin
Operating Income
$707M
16.9% margin
Net Income
$399M
9.5% margin
EPS (Diluted)
$0.33
QoQ Revenue Growth
-3.5%
Cash Flow
Operating Cash Flow
$1.1B
Free Cash Flow
$1.1B
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$53.5B
Total Liabilities
$33.0B
Stockholders' Equity
$20.4B
Cash & Equivalents
$752M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.2B
$4.4B
-5.4%
Gross Profit
$1.8B
$1.1B
+57.1%
Operating Income
$707M
-$266M
+365.7%
Net Income
$399M
-$1.0B
+138.5%
Revenue Segments
Brands
$2.6B
61%
Generics
$1.2B
30%
Complex GX and Biosimilars
$391M
9%
Geographic Segments
Developed Markets Segment
$2.5B
59%
Emerging Markets Segment
$705M
17%
Greater China Segment
$573M
14%
Japan, Australia and New Zealand Segment
$424M
10%
← FY 2022
All Quarters
Q2 2022 →